Catalytical nanogels reprogram immunosuppressive metabolic networks for activatable cancer photo-immunotherapy.
Metabolic dysregulation is a hallmark of cancer, making the modulation of these pathways an attractive therapeutic strategy; however, its clinical efficacy is often undermined by compensatory metabolic networks and inefficient tumor targeting effects. Here, we developed catalytical nanogels reprogramming immunosuppress...